Specifically, Harbin Pharmaceutical Group Co., Ltd. is a state-controlled Sino-foreign joint venture, with two public companies listed on the Shanghai Stock Exchange (namely Harbin Pharmaceutical Group Co., Ltd. and Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.) and 27 wholly-owned, holding and shareholding companies.
Harbin Pharmaceutical Group takes the pharmaceutical industry as the core, relies on modern logistics industry, adheres to the synchronous development of pharmaceutical industry and commerce, and develops into a competitive enterprise group integrating capital operation, production operation and scientific research.